SSR 125543A - CAS 321839-75-2
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Corticotropin-releasing factor (CRF)
SSR 125543A is a potent and orally bioactive corticotropin-releasing factor 1 receptor (CRF1) antagonist (pKi values of 8.73 and 9.08 for human cloned or native CRF1 receptors, respectively) with 1000-fold selectivity for CRF1 over CRF2α receptor and CRF binding protein. SSR 125543A exhibited antidepressant and anxiolytic properties in the Flinders Sensitive Line rats.
Brife Description:
CRF1 antagonist
SR-125543A; SR125543A; LS-150601; LS150601; LS 150601; 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-1,3-thiazol-2-amine hydrochloride
Canonical SMILES:
1.4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.
Griebel G;Simiand J;Steinberg R;Jung M;Gully D;Roger P;Geslin M;Scatton B;Maffrand JP;Soubrié P J Pharmacol Exp Ther. 2002 Apr;301(1):333-45.
The present study investigated the effects of the novel corticotrophin-releasing factor (CRF)(1) receptor antagonist 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A) in a variety of rodent models of anxiety, including conflict procedures (punished drinking and four-plate), exploration models (elevated plus-maze and light/dark), a fear/anxiety defense test battery, and several procedures based on stress-induced changes in physiological (isolation-induced hyperthermia and tail pinch-induced cortical norepinephrine release) or behavioral (social defeat-induced anxiety, maternal separation-induced vocalization) parameters. Moreover, the effects of SSR125543A were investigated in acute (forced swimming) and chronic (chronic mild stress; CMS) models of depression. SSR125543A and the CRF(1) receptor antagonist antalarmin displayed limited efficacy in exploration-based anxiety models. In contrast, both compounds produced clear-cut anxiolytic-like activity in models involving inescapable stress, including the conflict procedures, the social defeat-induced anxiety paradigm and the defense test battery (3-30 mg/kg i.
2.4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization.
Gully D;Geslin M;Serva L;Fontaine E;Roger P;Lair C;Darre V;Marcy C;Rouby PE;Simiand J;Guitard J;Gout G;Steinberg R;Rodier D;Griebel G;Soubrie P;Pascal M;Pruss R;Scatton B;Maffrand JP;Le Fur G J Pharmacol Exp Ther. 2002 Apr;301(1):322-32.
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1- (3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a new 2-aminothiazole derivative, shows nanomolar affinity for human cloned or native corticotrophin-releasing factor (CRF)(1) receptors (pK(i) values of 8.73 and 9.08, respectively), and a 1000-fold selectivity for CRF(1) versus CRF(2 alpha) receptor and CRF binding protein. SSR125543A antagonizes CRF-induced stimulation of cAMP synthesis in human retinoblastoma Y 79 cells (IC(50) = 3.0 +/- 0.4 nM) and adrenocorticotropin hormone (ACTH) secretion in mouse pituitary tumor AtT-20 cells. SSR125543A is devoid of agonist activity in these models. Its brain penetration was demonstrated in rats by using an ex vivo [(125)I-Tyr(0)] ovine CRF binding assay. SSR125543A displaced radioligand binding to the CRF(1) receptor in the brain with an ID(50) of 6.5 mg/kg p.o. (duration of action >24 h). SSR125543A also inhibited the increase in plasma ACTH levels elicited in rats by i.v. CRF (4 microg/kg) injection (ID(50) = 1, 5, or 5 mg/kg i.v., i.p., and p.o., respectively); this effect lasted for more than 6 h when the drug was given orally at a dose of 30 mg/kg.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Corticotropin-releasing factor (CRF) Products

(CAS: 195054-99-0)

NBI-30545 is a potent corticotropin-releasing factor-1 antagonist with proper lipophilicity (log D = 2.78) and good solubility in water (>10mg/mL), and exhibite...

Stressin I

Stressin I is a potent and selective corticotropin releasing factor receptor-1 (CRF1) agonist (Ki = 1.5 and 224 nM for CRF1 and CRF2 receptors, respectively). S...

(CAS: 195055-03-9)

R-121919 is a potent orally active small-molecule Corticotropin-Releasing factor 1 (CRF1) receptor antagonist for the treatment of anxiety and depression, while...

CAS 176591-49-4 Urocortin (human)

Urocortin (human)
(CAS: 176591-49-4)

Urocortin (human) is a neuropeptide hormone that acts as an endogenous CRF agonist (Ki = 0.4, 0.3 and 0.5 nM for hCRF1, rCRF2α and mCRF2β, respectively).

CAS 90880-23-2 α-helical CRF 9-41

α-helical CRF 9-41
(CAS: 90880-23-2)

α-helical CRF 9-41 has been found to be a corticotropin-releasing factor receptor antagonist.

CAS 434938-41-7 K 41498

K 41498
(CAS: 434938-41-7)

K 41498 is a potent and highly selective CRF2 receptor antagonist. Its Ki values are 425, 0.66 and 0.62 nM for human CRF1, CRF2α and CRF2β receptors respectivel...

CAS 257639-98-8 CP 154526

CP 154526
(CAS: 257639-98-8)

The hydrochloride salt form of CP-154526, which has been found to be a non-peptide CRF1 receptor antagonist and could exhibit anxiolytic-like activity at some e...

SSR 125543A
(CAS: 321839-75-2)

SSR 125543A is a potent and orally bioactive corticotropin-releasing factor 1 receptor (CRF1) antagonist (pKi values of 8.73 and 9.08 for human cloned or native...

Quick Inquiry

Verification code

Featured Items